ZyVersa Therapeutics Inc (ZVSA)

Precedente Chiudi:

$4.94

Aprire:

$4.9

Volume 24 ore:

25,047

Capitalizzazione di mercato:

$3.69M

Reddito:

-

Utile/perdita netta:

$-98.30M

Rapporto P/E:

-0.6741

EPS:

-7.2097

Flusso di cassa netto:

$-8.72M

1 W Prestazione:

-7.95%

1M Prestazione:

+741.49%

6M Prestazione:

+6,329%

1 anno Prestazione:

+1,175%

Intervallo 1D:

$4.83

$4.99

Portata 52W:

$0.0541

$6.70

ZyVersa Therapeutics Inc Stock (ZVSA) Company Profile

Nome

ZyVersa Therapeutics Inc

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

754 231 1688

Indirizzo

2200 N. Commerce Parkway, Suite 208, Weston

Dipendente

6

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

ZVSA's Discussions on Twitter

ZyVersa Therapeutics Inc Borsa (ZVSA) Ultime notizie

ZyVersa Therapeutics reports Q1 EPS ($4.53) vs. ($135.88) last year - TipRanks.com - TipRanks

TipRanks

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update - GlobeNewswire

GlobeNewswire

ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update

GlobeNewswire Inc.

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention - GlobeNewswire

GlobeNewswire

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention

GlobeNewswire Inc.

ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially ... - br.ADVFN.com

br.ADVFN.com

ZyVersa Therapeutics Inc Azioni (ZVSA) Dati Finanziari

ZyVersa Therapeutics Inc (ZVSA) Reddito netto 2024

ZyVersa Therapeutics Inc (ZVSA) Flusso di cassa 2024

ZyVersa Therapeutics Inc (ZVSA) Utile per azione 2024